140 related articles for article (PubMed ID: 3124767)
1. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
[TBL] [Abstract][Full Text] [Related]
3. [Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
Anai H; Maehara Y; Kusumoto H; Masuda H; Sugimachi K
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):635-8. PubMed ID: 3103537
[TBL] [Abstract][Full Text] [Related]
4. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571
[TBL] [Abstract][Full Text] [Related]
5. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
6. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
[TBL] [Abstract][Full Text] [Related]
7. The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Hirabayashi N; Nosoh Y; Niimoto M; Hattori T
Jpn J Surg; 1988 Nov; 18(6):725-8. PubMed ID: 2977626
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
9. [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2285-90. PubMed ID: 3136700
[TBL] [Abstract][Full Text] [Related]
10. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K
Dis Colon Rectum; 1988 Jan; 31(1):62-7. PubMed ID: 3130239
[TBL] [Abstract][Full Text] [Related]
11. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
[TBL] [Abstract][Full Text] [Related]
12. [Anti-tumor effects of carmofur on human 5-FU resistant cells].
Sato S; Ueyama T; Fukui H; Miyazaki K; Kuwano M
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1613-6. PubMed ID: 10553419
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
[TBL] [Abstract][Full Text] [Related]
15. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia potentiates the cytotoxic activity of 1-hexylcarbamoyl-5-fluorouracil in sarcoma-180 cells and human malignant tumor cells.
Kusumoto T; Maehara Y; Sakaguchi Y; Kohnoe S; Sugimachi K
Anticancer Res; 1991; 11(6):1963-6. PubMed ID: 1776828
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sakaguchi Y; Kido Y; Okamura T; Korenaga D; Sugimachi K
Cancer; 1989 May; 63(9):1693-6. PubMed ID: 2495166
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro.
Tsumura M; Yoshiga K; Takada K
Cancer Res; 1988 Jul; 48(14):3977-80. PubMed ID: 3383192
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of 1-hexycarbamoyl-5-fluorouracil in rats and human patients, and clinical results in patients with colorectal cancer].
Takashima S; Kinami Y; Kiriyama M; Tomita F; Ueno K; Miyazaki I
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):549-55. PubMed ID: 3954377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]